Abstract
T/NK cell lymphoma is a rare subtype of lymphoma that is known to be of aggressive nature. We present two cases of this disease that originally presented with symptoms consistent with chronic rhinosinusitis. We outline how we managed the diseases and review literature on it.
References
Li X, Liao W-H, Zhou J-H, Liu B-A, Wen J-F, Hu Z-L (2014) NK/T cell lymphoma involving mediastinum: report of a case and review of literature. Int J Clin Exp Pathol 7(9):6399–6402
Topham NJ, Hewitt EW (2009) Natural killer cell cytotoxicity: how do they pull the trigger? Immunology 128(1):7–15
Oshimi K (2007) Progress in understanding and managing natural killer-cell malignancies. Br J Haematol 139(4):532–544
Kwong Y-L (2005) Natural killer-cell malignancies: diagnosis and treatment. Leukemia 19(12):2186–2194
Yamaguchi M, Tobinai K, Oguchi M, Ishizuka N, Kobayashi Y, Isobe Y et al (2009) Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211. J Clin Oncol 27(33):5594–5600
Yamaguchi M, Suzuki R, Kwong Y-L, Kim WS, Hasegawa Y, Izutsu K et al (2008) Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia. Cancer Sci 99(5):1016–1020
Yok-Lam K (2011) The diagnosis and management of extranodal NK/T-cell lymphoma, nasal-type and aggressive NK-cell leukemia. J Clin Exp Hematopathol 51(1):21–28
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Ethical Approval
This article does not contain any studies with human participants performed by any of the authors.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Thawani, R., Seth, S., Singh, K. et al. Two Cases of NK/T Cell Lymphoma Presenting as Chronic Rhinosinusitis. Indian J Hematol Blood Transfus 33, 148–150 (2017). https://doi.org/10.1007/s12288-016-0709-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-016-0709-4